Form 4: Light & Wonder Director Dr. Kneeland Youngblood Acquires Shares Through RSU Vesting
Insider Transaction Report
Dr. Kneeland Youngblood, a Director at Light & Wonder, Inc., has acquired 2,159 shares of common stock through the vesting of restricted stock units.
Summary
- Dr. Kneeland Youngblood, a Director of Light & Wonder, Inc. (LNW), reported a transaction on June 5, 2025.
- The transaction involved the acquisition of 2,159 shares of Light & Wonder common stock.
- These shares were acquired at a price of $0, resulting from the vesting of previously granted restricted stock units (RSUs).
- The RSUs were originally granted on June 5, 2024, and have now fully vested, converting on a one-for-one basis into common stock.
- Following this transaction, Dr. Youngblood directly beneficially owns 28,164 shares of Light & Wonder common stock.
Sentiment
Score: 7
Explanation: The sentiment is positive as it indicates a director's equity stake increasing through a routine, non-cash vesting event, aligning their interests with shareholders. There are no negative implications from this specific filing.
Positives
- The vesting of restricted stock units at a $0 price represents a non-cash acquisition of shares, increasing the director's direct equity stake in the company.
- This transaction aligns the director's interests more closely with those of the shareholders, as their personal wealth is now more tied to the company's stock performance.
- The increase in direct beneficial ownership to 28,164 shares demonstrates continued commitment from a key board member.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.
Industry Context
This specific Form 4 filing details a routine insider transaction related to equity compensation, which is a common practice across all industries, including the gaming and lottery industry where Light & Wonder operates. It does not provide broader industry trends or competitive insights.
Stakeholder Impact
- Shareholders: The increase in direct share ownership by a director can be viewed positively as it strengthens alignment between management/board and shareholder interests.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 06/05/2024 | Date when the Restricted Stock Units (RSUs) were originally granted to Dr. Kneeland Youngblood. |
| 06/05/2025 | Date of the transaction, representing the vesting of 2,159 Restricted Stock Units and their conversion into common stock. |
| 06/06/2025 | Date the Form 4 filing was signed by the attorney-in-fact for Dr. Kneeland Youngblood. |
Keywords
Light & Wonder, LNW, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Stock Ownership, Equity Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.